Plasmodium falciparum antigens inducing protective antibodies
US6472519B1 · kind B1 · utility
4Cited by
20References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1999 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | Jul 19, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A molecule, protein or peptide characterized in that it is recognized by cytophilic antibodies from individuals who are immune to infection by Plasmodia, and recognized by non-cytophilic antibodies from individuals who are vulnerable to infection by Plasmodiae. Said antibodies are capable of blocking the erythrocytic phase of the parasite by co-operating with accessory cells such as monocytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.